To confirm that cytopiloyne reduced hyperglycemia by stimulating insulin production from pancreatic β cells in vivo, we tested its ability to reduce hyperglycemia and to augment insulin levels in STZ-treated C57BL mice whose β cells were already depleted. The gene discussed is INS; the disease is Hyperglycemia.